1. A pharmacist who has entered into a valid collaborative practice agreement may engage in the collaborative practice of pharmacy or collaborative drug therapy management at any location in this State.
2. To enter into a collaborative practice agreement, a practitioner must:
(a) Be licensed in good standing to practice his or her profession in this State; and
(b) Agree to obtain the informed, written consent from a patient who is referred by the practitioner to a pharmacist pursuant to a collaborative practice agreement for collaborative drug therapy management. The provisions of this paragraph must not be construed to require a patient to obtain a referral from a practitioner before a pharmacist may engage in the collaborative practice of pharmacy or collaborative drug therapy management.
3. A practitioner shall not enter into a collaborative practice agreement with a collaborating pharmacist if the geographic distance between the practitioner and the collaborating pharmacist prevents or limits effective collaboration in the delivery of care or treatment to patients.
4. Except as otherwise provided in this subsection, a practitioner shall not enter a collaborative practice agreement that includes diagnosis or initiating treatment unless the practitioner actively practices his or her profession in this State or provides those services using telehealth. The Board may grant a written request for an exemption from the requirements of this subsection for good cause shown.
5. A collaborative practice agreement must not grant a pharmacist the authority to engage in an activity that is outside the scope of the current practice of the practitioner.
6. A pharmacist who engages in the collaborative practice of pharmacy shall:
(a) Except as otherwise provided in paragraph (b), document any treatment or care provided to a patient pursuant to a collaborative practice agreement after providing such treatment or care in the medical record of the patient, on the chart of the patient or in a separate log book;
(b) Document in the medical record of the patient, on the chart of the patient or in a separate log book any decision or action concerning the management of drug therapy pursuant to a collaborative practice agreement after making such a decision or taking such an action;
(c) Maintain all records concerning the care or treatment provided to a patient pursuant to a collaborative practice agreement in written or electronic form for at least 7 years;
(d) Comply with all provisions of the Health Insurance Portability and Accountability Act of 1996, Public Law 104-191, the regulations adopted pursuant thereto, and all other federal and state laws and regulations concerning the privacy of information regarding health care; and
(e) Provide a patient with written notification of:
(1) Any test administered by the pharmacist and the results of such a test;
(2) The name of any drug or prescription filled and dispensed by the pharmacist to the patient; and
(3) The contact information of the pharmacist.
7. A pharmacist shall obtain the informed, written consent of a patient before engaging in the collaborative practice of pharmacy on behalf of the patient. Such written consent must include, without limitation, a statement that the pharmacist:
(a) May initiate, modify or discontinue the medication of the patient pursuant to a collaborative practice agreement; and
(b) Is not a physician, osteopathic physician, advanced practice registered nurse or physician assistant.
8. A pharmacy must not require a registered pharmacist, as a condition of employment, to enter into a collaborative practice agreement.
(Added to NRS by 2017, 2519; A 2021, 1660)
Structure Nevada Revised Statutes
Chapter 639 - Pharmacists and Pharmacy
NRS 639.0015 - "Advanced practice registered nurse" defined.
NRS 639.0017 - "Biological product" defined.
NRS 639.002 - "Board" defined.
NRS 639.003 - "Certificate" defined.
NRS 639.004 - "Chart order" defined.
NRS 639.005 - "Chemical" defined.
NRS 639.0051 - "Collaborative drug therapy management" defined.
NRS 639.0052 - "Collaborative practice agreement" defined.
NRS 639.00525 - "Collaborative practice of pharmacy" defined.
NRS 639.0053 - "Compound" and "compounding" defined.
NRS 639.006 - "Conviction" defined.
NRS 639.0061 - "Course of treatment" defined.
NRS 639.0065 - "Dispense" defined.
NRS 639.007 - "Drug" and "medicine" defined.
NRS 639.0071 - "Drug sample" defined.
NRS 639.0073 - "Fill" defined.
NRS 639.0074 - "Hospital" defined.
NRS 639.008 - "Hypodermics" defined.
NRS 639.0082 - "Initial prescription" defined.
NRS 639.0085 - "Institutional pharmacy" defined.
NRS 639.00855 - "Interchangeable biological product" defined.
NRS 639.0086 - "Intern pharmacist" defined.
NRS 639.00865 - "Internet pharmacy" defined.
NRS 639.0087 - "Managing pharmacist" defined.
NRS 639.009 - "Manufacturer" defined.
NRS 639.0095 - "Nuclear pharmacist" defined.
NRS 639.0097 - "Nuclear pharmacy" defined.
NRS 639.0105 - "Parenteral solutions" and "parenterals" defined.
NRS 639.0113 - "Pharmaceutical technician" defined.
NRS 639.0115 - "Pharmaceutical technician in training" defined.
NRS 639.012 - "Pharmacy" defined.
NRS 639.0123 - "Pharmacy in a correctional institution" defined.
NRS 639.0125 - "Practitioner" defined.
NRS 639.013 - "Prescription" defined.
NRS 639.0143 - "Radiopharmaceutical" defined.
NRS 639.0144 - "Recovery center" defined.
NRS 639.0145 - "Refill" defined.
NRS 639.015 - "Registered pharmacist" defined.
NRS 639.0151 - "Remote site" defined.
NRS 639.0153 - "Satellite consultation site" defined.
NRS 639.01531 - "Self-administered hormonal contraceptive" defined. [Effective January 1, 2022.]
NRS 639.01535 - "Telehealth" defined.
NRS 639.0154 - "Telepharmacy" defined.
NRS 639.0155 - "Wholesale distribution" defined.
NRS 639.016 - "Wholesaler" defined.
NRS 639.018 - Inapplicability of chapter to certain veterinary biologic products.
NRS 639.020 - Creation; number and appointment of members.
NRS 639.030 - Qualification and terms of members; oath; vacancies; grounds for removal from office.
NRS 639.060 - Biennial report to Governor.
NRS 639.065 - Annual report concerning immunizations administered by pharmacists.
NRS 639.067 - Posting of information relating to pharmaceutical manufacturers on website.
NRS 639.070 - General powers; regulations.
NRS 639.071 - Regulations: Institutional pharmacies.
NRS 639.072 - Regulations: Pharmacies in correctional institutions.
NRS 639.0725 - Regulations: Internet pharmacies.
NRS 639.0747 - Regulations: Registered pharmacists collecting specimens.
NRS 639.090 - Enforcement of chapter; inspections.
NRS 639.093 - Communication with other public agencies; immunity.
NRS 639.095 - Board to furnish free copies of law and regulations to applicants and registrants.
NRS 639.097 - Injunctive relief.
NRS 639.120 - Qualifications of applicants to become registered pharmacists.
NRS 639.134 - Registration of pharmacist without examination; reciprocity.
NRS 639.138 - Denial of application: Notice.
NRS 639.139 - Denial of application: Procedure for reconsideration.
NRS 639.150 - Display of certificates, licenses and permits; regulations.
NRS 639.160 - Notice of new place of practice.
NRS 639.170 - Fees; costs of special meetings; regulations.
NRS 639.190 - Issuance of certificate of registration as pharmacist after forfeiture.
NRS 639.200 - Issuance of duplicate certificates and receipts for renewal.
NRS 639.211 - Mental illness: Immediate suspension of right to practice.
NRS 639.213 - Legislative declaration.
NRS 639.2171 - Legislative findings and declaration.
NRS 639.2177 - License; regulations.
NRS 639.231 - Application for and issuance of license.
NRS 639.232 - Limitations on issuance of licenses.
NRS 639.2324 - Institutional pharmacies: Requirements for operation.
NRS 639.2327 - Maintenance of stocks of drugs by certain facilities.
NRS 639.23277 - Remote sites and satellite consultation sites: Location; operation; regulations.
NRS 639.23286 - Pharmacy located outside Nevada: Substitution of drug; toll-free telephone service.
NRS 639.233 - License required.
NRS 639.2345 - Sale of veterinary drugs: Permit required; regulations; exemption.
NRS 639.2355 - Practitioner liable for prescription orally transmitted by agent.
NRS 639.236 - Numbering, filing and retention of prescriptions; inspection of files; regulations.
NRS 639.2392 - Controlled substance or dangerous drug: Records.
NRS 639.2393 - Controlled substance or dangerous drug: Limitations.
NRS 639.2394 - Controlled substance or dangerous drug: Exercise of judgment by pharmacist.
NRS 639.2395 - Early refills for topical ophthalmic products authorized under certain circumstances.
NRS 639.2396 - Specific authorization; limitations.
NRS 639.2397 - Rescission of authorization.
NRS 639.241 - Accusation: Form, contents and signature.
NRS 639.243 - Statement to Respondent: Contents.
NRS 639.244 - Notice of Defense: Form; effect of failure to file.
NRS 639.245 - Notice of hearing.
NRS 639.246 - Subpoenas; payment of witness fees and expenses.
NRS 639.247 - Hearing: Procedure.
NRS 639.248 - Hearing: Use of hearsay evidence.
NRS 639.251 - Decision; order.
NRS 639.253 - Order following rehearing.
NRS 639.2535 - Judicial review.
NRS 639.2565 - Reinstatement of suspended certificate.
NRS 639.257 - Reinstatement of revoked certificate, license or permit.
NRS 639.2576 - Immunity from civil action for assisting administrative proceeding.
NRS 639.258 - Filing of complaint.
NRS 639.2583 - General requirements governing substitution; procedure; limitations; exceptions.
NRS 639.2595 - Liability of pharmacist or practitioner.
NRS 639.2597 - Use of list of biologically equivalent drugs or interchangeable biological products.
NRS 639.263 - False or misleading advertising.
NRS 639.264 - Prohibition against unearned rebate, refund or other consideration for referrals.
NRS 639.265 - Pharmacists may trade or exchange drugs if necessary for business.
NRS 639.266 - Communication of information to patient or person caring for patient.
NRS 639.275 - Computer or other electronic device provided to practitioner by pharmacy or insurer.
NRS 639.2801 - Requirements for labeling containers for prescribed drugs.
NRS 639.2802 - Availability of information concerning prices of prescriptions.
NRS 639.2803 - Dispensing specific drugs when choice of drugs available.
NRS 639.2804 - Filling prescriptions for amygdalin and procaine hydrochloride.
NRS 639.2806 - Parenteral solutions: Limitation on sale and dispensing.
NRS 639.2807 - Parenteral solutions: Compounding, packaging and labeling; regulations.
NRS 639.281 - False representations.
NRS 639.2815 - Fraudulent or excessive charge or claim under program of public assistance; penalty.
NRS 639.2825 - Unlawful to sell, furnish or fit contact lens; exception.
NRS 639.284 - Unlawful dispensing and sales; penalties.
NRS 639.2845 - Selling or dispensing of procaine hydrochloride.
NRS 639.285 - Unlawful sales by unlicensed persons; penalties.
NRS 639.286 - Violation of Board’s regulations.
NRS 639.288 - Unlawful sales by wholesalers and manufacturers.
NRS 639.289 - Inspection of premises by Board.
NRS 639.2893 - Practicing or offering to practice without license: Reporting requirements of Board.
NRS 639.2895 - Practicing or offering to practice without license: Penalties.
NRS 639.300 - Recovery of penalties; conduct of actions and prosecutions by district attorney.
NRS 639.310 - Criminal penalty.
NRS 639.400 - "Product that is a precursor to methamphetamine" defined.
NRS 639.410 - Sales of products that are precursors to methamphetamine.
NRS 639.430 - Real-time, stop sale system: Conditions for approval; regulations.
NRS 639.510 - Protection of certain information obtained by Board.
NRS 639.515 - Bond or other form of security required; exceptions.
NRS 639.535 - Statement of prior sales" or "statement" defined.
NRS 639.540 - Duties of Board; requirements concerning use, form and contents of statement.
NRS 639.545 - Prohibited transactions.
NRS 639.555 - Additional unlawful acts.
NRS 639.575 - Information regarding other wholesalers.
NRS 639.580 - Evidence regarding due diligence; prohibited business relationships.
NRS 639.585 - On-site inspections; agreements with other wholesalers.